Announcements Trials

Browse Landscape

Phase

Phase 1 2 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 52 Insulin Resistance 12 Metabolic Syndrome 4 Hyperandrogenism 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Obesity 3 Breast Neoplasms 3 Weight Loss 2 Rare Diseases 2 Infertility, Female 2 Hyperinsulinism 2 Endocrine System Diseases 2 Thyroid Nodule 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Prostatic Neoplasms 1 Premature Birth 1 Obesity, Morbid 1 Metformin 1 Menstruation Disturbances 1 Inflammation 1 Infertility 1 Hyperglycemia 1 Head and Neck Neoplasms 1 Glucose Intolerance 1 Endometrial Neoplasms 1 Diabetes Mellitus 1 Depression 1

Interventions

Radiotherapy 10 fludarabine phosphate 9 Peripheral Blood Stem Cell Transplantation 8 Cyclosporine 7 Cyclophosphamide 7 Busulfan 7 Whole-Body Irradiation 6 Melphalan 6 Radiofrequency Ablation 5 Mycophenolic Acid 5 Filgrastim 5 Antilymphocyte Serum 5 Surveys and Questionnaires 4 Surgical Procedures, Operative 4 Methotrexate 4 Etoposide 4 Drug Therapy 4 Cisplatin 4 fludarabine 3 Radiosurgery 3 Injections 3 Hepatectomy 3 Cord Blood Stem Cell Transplantation 3 thymoglobulin 2 lenvatinib 2 Vinblastine 2 Videotape Recording 2 Thiotepa 2 Standard of Care 2 Sorafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Recurrence × Metformin × Clear all

NCT03538704 2018-05-29

ECFerSp

Peking University People's Hospital

Phase NA Unknown

Recurrence, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡